Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
Condition: Malaria Interventions: Biological: PfSPZ Vaccine; Other: PfSPZ Diluent; Drug: Normal Saline Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Infectious Diseases | Malaria | Malaria Vaccine | Mali Health | Pregnancy | Research | Vaccines | Women